John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
EA
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.33% |
| 2 | Technology | 13.07% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Financials | 9.32% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGBK
1726
DELISTED
Stonegate Bank
SGBK
| $1.02M | ﹤0.01% |
31,730
+12,981
| +69% | +$404K |
|
|
BOXC
1727
DELISTED
Brookfield Can Office Properties
BOXC
| $1.02M | ﹤0.01% |
46,280
+33,074
| +250% | +$731K |
|
1728
Natural Gas Services Group
NGS
$448M
| $1.02M | ﹤0.01% |
44,597
-119
| -0.3% | -$2.66K |
|
|
TRIB
1729
Trinity Biotech
TRIB
$7.8M
| $1.02M | ﹤0.01% |
600
-193
| -24% | -$326K |
|
|
SCLN
1730
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $1.02M | ﹤0.01% |
78,189
+56,370
| +258% | +$739K |
|
1731
Glaukos
GKOS
$10.7B
| $1.02M | ﹤0.01% |
+34,893
| New | +$808K |
|
1732
FormFactor
FORM
$8.44B
| $1.02M | ﹤0.01% |
113,050
+87,650
| +345% | +$660K |
|
|
LBY
1733
DELISTED
Libbey, Inc.
LBY
| $1.01M | ﹤0.01% |
63,882
-3,170
| -5% | -$54.4K |
|
|
RSE
1734
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $1.01M | ﹤0.01% |
55,571
+37,625
| +210% | +$689K |
|
1735
PUT
Genuine Parts
GPC
$19.2B
| $1.01M | ﹤0.01% |
10,000
+5,000
| +100% | +$485K |
|
|
KW
1736
DELISTED
Kennedy-Wilson Holdings
KW
| $1.01M | ﹤0.01% |
53,366
-23,960
| -31% | -$496K |
|
1737
CALL
Progressive
PGR
$129B
| $1.01M | ﹤0.01% |
+30,200
| New | +$999K |
|
|
NFX
1738
CALL
DELISTED
Newfield Exploration
NFX
| $1.01M | ﹤0.01% |
22,800
+2,800
| +14% | +$107K |
|
1739
PUT
Applied Materials
AMAT
$381B
| $1M | ﹤0.01% |
41,900
-76,100
| -64% | -$1.68M |
|
1740
CALL
Capital One
COF
$133B
| $1M | ﹤0.01% |
15,800
+12,800
| +427% | +$891K |
|
1741
Matsons
MATX
$6.63B
| $1M | ﹤0.01% |
31,072
+17,832
| +135% | +$617K |
|
1742
PUT
Targa Resources
TRGP
$63B
| $1M | ﹤0.01% |
23,800
+12,900
| +118% | +$506K |
|
|
ALE
1743
DELISTED
Allete
ALE
| $1M | ﹤0.01% |
15,497
-36,144
| -70% | -$2.08M |
|
1744
CALL
Pultegroup
PHM
$24.8B
| $998K | ﹤0.01% |
51,200
+3,200
| +7% | +$59.3K |
|
1745
Saia
SAIA
$9.31B
| $998K | ﹤0.01% |
39,714
-30,809
| -44% | -$820K |
|
1746
Culp Inc
CULP
$43.6M
| $996K | ﹤0.01% |
36,030
+9,416
| +35% | +$256K |
|
|
CXO
1747
DELISTED
CONCHO RESOURCES INC.
CXO
| $995K | ﹤0.01% |
+8,345
| New | +$968K |
|
|
BFIN
1748
DELISTED
BankFinancial
BFIN
| $994K | ﹤0.01% |
+82,933
| New | +$1.02M |
|
|
WSTC
1749
DELISTED
West Corporation
WSTC
| $992K | ﹤0.01% |
50,483
+23,498
| +87% | +$504K |
|
|
SQI
1750
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $992K | ﹤0.01% |
56,173
-61,111
| -52% | -$927K |
|
Similar funds
John Overdeck's Q2 2016 Portfolio in Review
As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
- John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- John Overdeck fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- John Overdeck opened 779 new positions and closed 661 in Q2 2016.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.